Victory Capital Management’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-88
| Closed | -$5K | – | 2774 |
|
|
2022
Q2 | $5K | Sell |
88
-1
| -1% | -$57 | ﹤0.01% | 2680 |
|
|
2022
Q1 | $5K | Buy |
89
+13
| +17% | +$730 | ﹤0.01% | 2705 |
|
|
2021
Q4 | $5K | Sell |
76
-2
| -3% | -$132 | ﹤0.01% | 2757 |
|
|
2021
Q3 | $9K | Sell |
78
-4
| -5% | -$462 | ﹤0.01% | 2763 |
|
|
2021
Q2 | $12K | Sell |
82
-1
| -1% | -$146 | ﹤0.01% | 2727 |
|
|
2021
Q1 | $14K | Buy |
+83
| New | +$14K | ﹤0.01% | 2734 |
|
|
2020
Q2 | – | Sell |
-23
| Closed | -$2K | – | 3225 |
|
|
2020
Q1 | $2K | Buy |
+23
| New | +$2K | ﹤0.01% | 3679 |
|
|
2019
Q4 | – | Sell |
-11
| Closed | -$1K | – | 3230 |
|
|
2019
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 3721 |
|